High-fat diet-induced kidney alterations in rats with metabolic syndrome: endothelial dysfunction and decreased antioxidant defense
Related Experiment Video
Updated: Jan 18, 2026

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
Raquel Rangel Silvares1, Evelyn Nunes Goulart da Silva Pereira1, Edgar Eduardo Ilaquita Flores1
1Laboratory of Cardiovascular Investigation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Introduction:
This study aimed to investigate changes in renal function and the AGE-RAGE axis in the kidney of a non-genetic animal model of metabolic syndrome (MetS) induced by high-fat diet (HFD). Additionally, we evaluated the protective effect of pyridoxamine (PM), a vitamin B6 analog with anti-AGE effects, in the context of diet-related renal endothelial dysfunction.
Methodology:
In Wistar rats, the MetS animal model was induced by 20 or 28 weeks of HFD feeding. When indicated, a subgroup of animals was treated daily with PM (60 mg/kg) for 2 months. Tissue perfusion in renal microcirculation was examined by laser speckle contrast imaging. Oxidative stress was analyzed by thiobarbituric acid reactive species and the inflammatory markers by ELISA (TNF-α and IL-1β). Reverse transcription polymerase chain reaction was used to analyze eNOs, IL-6, vascular cell adhesion molecule (VCAM), NADPH oxidase subunit 47 (N47), catalase, and receptor for AGE (RAGE) gene expression.
Results:
Wistar rats fed a HFD showed negligible alteration in renal function, decrease in catalase mRNA transcripts and catalase enzyme activity compared to control (CTL) animals. Increased levels of IL-1β were observed in the kidney of MetS-induced rats. HFD-fed rats exhibited kidney endothelial dysfunction, with no significant differences in basal microvascular blood flow. PM significantly improved kidney vasorelaxation in HFD-fed rats. eNOS, VCAM, and RAGE gene expression and AGE content were not altered in kidneys of HFD-induced MetS rats in comparison to CTLs.
Conclusions:
Our findings suggest that HFD-induced microvascular dysfunction precedes the decline in renal function, and could be related to antioxidant machinery defects and inflammation activation in the kidney. PM showed a vasoprotective effect, and thus, could be an important contributory factor in ameliorating diet-induced renal damage.
Insights
High-fat diets cause kidney microvascular dysfunction before renal decline, linked to inflammation. Pyridoxamine (PM) offers protection against this diet-induced kidney damage.
Area of Science:
- Nephrology
- Metabolic Syndrome Research
- Vascular Biology
Background:
- Metabolic syndrome (MetS) induced by high-fat diet (HFD) can affect renal function.
- The role of the advanced glycation end-product (AGE)-receptor for AGE (RAGE) axis in diet-induced kidney damage is not fully understood.
- Diet-related renal endothelial dysfunction is a growing concern.
Purpose of the Study:
- To investigate changes in renal function and the AGE-RAGE axis in a non-genetic animal model of MetS induced by HFD.
- To evaluate the protective effect of pyridoxamine (PM) against diet-related renal endothelial dysfunction.
Main Methods:
- MetS was induced in Wistar rats via HFD for 20 or 28 weeks.
- Pyridoxamine (PM) treatment was administered to a subgroup of HFD-fed rats.
- Renal microcirculation, oxidative stress, inflammation, and gene expression (eNOS, VCAM, RAGE) were analyzed.
Main Results:
- HFD induced kidney endothelial dysfunction and increased IL-1β levels.
- Catalase activity and mRNA were decreased in HFD-fed rats.
- PM treatment improved kidney vasorelaxation in HFD-fed rats, despite no changes in RAGE or AGE levels.
Conclusions:
- HFD-induced microvascular dysfunction precedes renal function decline and may involve inflammation and antioxidant defects.
- Pyridoxamine (PM) demonstrates vasoprotective effects, suggesting its potential in mitigating diet-induced renal damage.
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Hypertension II: Pathophysiology
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...